Which ASX Small-Cap Stocks in Consumer, Mining, and Tech Sectors Are Gaining Market Attention on XSO and XEC?

Highlights

• ASX-listed Funtastic (FUN) active in the consumer products space, recently merged with another company

• Azure Minerals (AZS) operating in the exploration sector, known for lithium-related developments

• Family Zone Cyber Safety (FZO) positioned in the cybersecurity segment, expanding school-focused software solutions

Funtastic Ltd (ASX:FUN), operating in the consumer products sector and listed on the ASX 200, XSO, and XEC indices, has been involved in the sourcing and distribution of toys, educational products, and related merchandise. Following a merger with Toys“R”Us ANZ, the company has transitioned its business model to focus on retail and eCommerce channels across Australia and New Zealand. This corporate change has integrated retail supply chain operations with digital retail infrastructure, supporting expanded activity in licensed toy brands and proprietary labels.

The company continues to engage with multiple global licensors, supporting its product lines across digital and physical marketplaces. Strategic alliances in the retail segment remain central to the company’s operational direction as it adapts to the evolving consumer goods landscape.

Exploration and Mining – AZS (XSO, XEC)

Azure Minerals Ltd (ASX:AZS), listed on the XSO and XEC indices, focuses on exploration activities with a primary interest in lithium and base metals. The company’s tenements are located in Western Australia, an area that remains relevant in the context of global battery material sourcing. Recent developments at its flagship site in the Pilbara region have highlighted mineralised pegmatites, contributing to growing attention in the lithium space.

The company has entered into partnerships with other listed entities to manage certain projects and to optimise resource mapping. Drill programs continue to assess mineral content, supported by external geological consultants. AZS has maintained its exploration schedule while complying with regulatory frameworks and environmental oversight.

Cybersecurity and EdTech – FZO (XSO, XEC)

Family Zone Cyber Safety Ltd (ASX:FZO), included in the XSO and XEC indices, operates in the cybersecurity and education technology segment. The company’s core offering involves cloud-based safety platforms tailored for educational institutions. Through school-wide implementation of filtering and monitoring solutions, FZO enables schools to align with national safety standards for online learning environments.

Recent product rollouts have extended FZO’s presence into overseas education markets. Strategic agreements with educational departments have contributed to a broader customer base, with software now implemented across multiple school networks. FZO continues to focus on technology refinement and integration to enhance school-wide digital safety capabilities.

Fintech and Payments – IOU (XSO, XEC)

IOUpay Ltd (ASX:IOU), featured on both XSO and XEC indices, engages in digital transaction processing services. The company has been active in Southeast Asia’s payments sector, delivering services such as Buy Now Pay Later (BNPL) and mobile financial platforms. IOUpay’s operations primarily serve licensed financial institutions and telecommunications networks.

The company has completed several integrations with merchant platforms, and its digital onboarding systems are supported by proprietary identification technology. Transaction growth and client acquisition continue to be focal points as IOU navigates regional digital finance frameworks.

Biotechnology and Diagnostics – RSH (XSO, XEC)

Respiri Ltd (ASX:RSH), a participant in the XSO and XEC indices, is positioned in the respiratory health technology space. The company’s core solution involves a handheld device for remote monitoring of respiratory conditions such as asthma. It includes a connected mobile application used by patients and healthcare professionals.

The business has entered distribution arrangements with healthcare providers and pharmacies, primarily in the US and Australian markets. Its technology is integrated into clinical practice workflows, and efforts are ongoing to align product features with remote patient management trends in respiratory care.